Rémi Quirion

38.4k total citations · 2 hit papers
546 papers, 31.9k citations indexed

About

Rémi Quirion is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Rémi Quirion has authored 546 papers receiving a total of 31.9k indexed citations (citations by other indexed papers that have themselves been cited), including 385 papers in Cellular and Molecular Neuroscience, 330 papers in Molecular Biology and 122 papers in Physiology. Recurrent topics in Rémi Quirion's work include Neuropeptides and Animal Physiology (230 papers), Receptor Mechanisms and Signaling (217 papers) and Neuroscience and Neuropharmacology Research (132 papers). Rémi Quirion is often cited by papers focused on Neuropeptides and Animal Physiology (230 papers), Receptor Mechanisms and Signaling (217 papers) and Neuroscience and Neuropharmacology Research (132 papers). Rémi Quirion collaborates with scholars based in Canada, United States and France. Rémi Quirion's co-authors include Stéphane Bastianetto, Yvan Dumont, Satyabrata Kar, Weiya Ma, Dalia M. Araujo, Lalit K. Srivastava, Jean‐Guy Chabot, Sylvain Doré, Wenhua Zheng and Paul A. Lapchak and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Rémi Quirion

540 papers receiving 31.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A proposal for the classification of sigma binding sites

1992 689 citations Rémi Quirion et al. profile →
Alzheimer’s disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies

2002 572 citations Stéphane Bastianetto, Rémi Quirion et al. profile →

Peers

Countries citing papers authored by Rémi Quirion

Since Specialization

Citations

This map shows the geographic impact of Rémi Quirion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rémi Quirion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rémi Quirion more than expected).

Fields of papers citing papers by Rémi Quirion

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rémi Quirion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rémi Quirion. The network helps show where Rémi Quirion may publish in the future.

Co-authorship network of co-authors of Rémi Quirion

This figure shows the co-authorship network connecting the top 25 collaborators of Rémi Quirion. A scholar is included among the top collaborators of Rémi Quirion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rémi Quirion. Rémi Quirion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Possible Role of Dynorphins in Alzheimer's Disease and Age-Related Cognitive Deficits 2013 ·Neurodegenerative Diseases ·Caroline Ménard, Herbert Herzog, Christoph Schwarzer, Rémi Quirion	21
2	The possible role of the Akt signaling pathway in schizophrenia 2012 ·Brain Research ·Wenhua Zheng, Haitao Wang, Zhiwen Zeng, Jun Lin, Peter J. Little, Lalit K. Srivastava, Rémi Quirion	108
3	Inhibition of SNL-induced upregulation of CGRP and NPY in the spinal cord and dorsal root ganglia by the 5-HT2A receptor antagonist ketanserin in rats 2012 ·Pharmacology Biochemistry and Behavior ·Dongmei Wang, Tingjun Chen, Yun Gao, Rémi Quirion, Yanguo Hong	13
4	α7 Nicotinic receptor activation reduces β‐amyloid‐induced apoptosis by inhibiting caspase‐independent death through phosphatidylinositol 3‐kinase signaling 2011 ·Journal of Neurochemistry ·Wenfeng Yu, Naguib Mechawar, Slavica Krantic, Rémi Quirion	53
5	Evidence for the Involvement of Apoptosis-Inducing Factor–Mediated Caspase-Independent Neuronal Death in Alzheimer Disease 2010 ·American Journal Of Pathology ·Wenfeng Yu, Naguib Mechawar, Slavica Krantic, Rémi Quirion	48
6	Papel de la adrenomedulina cerebelosa en la hipertensión arterial 2007 ·(unknown), (unknown), (unknown), (unknown), (unknown), Rémi Quirion, Anita Israel	5
7	Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation 2006 ·BMC Neuroscience ·Stéphane Bastianetto, Marc Danik, Françoise Mennicken, Sylvain Williams, Rémi Quirion	31
8	Expression of cortical and hippocampal apoptosis-inducing factor (AIF) in aging and Alzheimer's disease 2006 ·Neurobiology of Aging ·Stéphanie Reix, Naguib Mechawar, Santos A. Susín, Rémi Quirion, Slavica Krantic	30
9	Long-Lasting Rescue of Age-Associated Deficits in Cognition and the CNS Cholinergic Phenotype by a Partial Agonist Peptidomimetic Ligand of TrkA 2004 ·Journal of Neuroscience ·Martín A. Bruno, Paul B. S. Clarke, Alicia Seltzer, Rémi Quirion, Kevin Burgess, A. Claudio Cuello, H. Uri Saragovi	76
10	Early environment contributes to developmental disruption of MPFC after neonatal ventral hippocampal lesions in rats 2003 ·Synapse ·Graham K. Wood, Rémi Quirion, Lalit K. Srivastava	26
11	EGb 761 is a neuroprotective agent against beta-amyloid toxicity. 2002 ·PubMed ·Stéphane Bastianetto, Rémi Quirion	25
12	Neuroprotective and neurorescuing effects of isoform‐specific nitric oxide synthase inhibitors, nitric oxide scavenger, and antioxidant against beta‐amyloid toxicity 2001 ·British Journal of Pharmacology ·Angeline Law, Serge Gauthier, Rémi Quirion	39
13	[Nphe¹]‐Nociceptin (1‐13)‐NH₂, a nociceptin receptor antagonist, reverses nociceptin‐induced spatial memory impairments in the Morris water maze task in rats 2000 ·British Journal of Pharmacology ·J.P. Redrobe, Girolamo Calò, Remo Guerrini, D. Regoli, Rémi Quirion	41
14	Ionotropic glutamate receptor subtypes in the aged memory-impaired and unimpaired Long–Evans rat 1996 ·Neuroscience ·Hélène Le Jeune, Danielle Cécyre, Wayne Rowe, Michael J. Meaney, Rémi Quirion	57
15	Nicotinic acetylcholine receptors are decreased in rat dentate gyrus following entorhinal cortex lesions 1992 ·The Society for Neuroscience Abstracts ·Isabelle Aubert, Judes Poirier, A. Baccichet, Serge Gauthier, Rémi Quirion	2
16	Alterations in spinal cord excitatory amino acid receptors in amyotrophic lateral sclerosis patients 1992 ·Brain Research ·(unknown), Isabelle Chaudieu, Charles Krieger, Patricia Boksa, Alain Privat, Rémi Quirion	37
17	The International Narcotics Research Conference (INRC) '89 : proceedings of a conference held at Ste-Adèle, Québec, Canada, July 9-14, 1989 1990 ·Rémi Quirion, Khem Jhamandas, Christina Gianoulakis	1
18	Pharmacological activity of N-methyl-carbamylcholine, a novel acetylcholine receptor agonist with selectivity for nicotinic receptors 1989 ·European Journal of Pharmacology ·Patricia Boksa, Maryka Quik, John B. Mitchell, B. Collier, William M. O’Neil, Rémi Quirion	17
19	Effect of hydrocortisone on basal and apomorphine-induced growth hormone secretion in normal subjects. 1988 ·PubMed ·Lal S, (unknown), Iona Isaac, H. Guyda, Rémi Quirion	9
20	Differential Alteration of Various Cholinergic Markers in Cortical and Subcortical Regions of Human Brain in Alzheimer's Disease 1988 ·Journal of Neurochemistry ·Dalia M. Araujo, Paul A. Lapchak, Yves Robitaille, Serge Gauthier, Rémi Quirion	278

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact